Your support in 2020 helped us reach these milestones at LCFA
Each year has been an opportunity to see strides made in lung cancer research. Here’s a glimpse at what accomplishments you helped the LCFA team achieve toward our mission:
lung cancer community
Shared milestone lung cancer stories
One of the most visited sections of LCFA’s website are the stories of people living with lung cancer.
Stories of inspirational people living with lung cancer. Testimonies illustrating how research breakthroughs in lung cancer diagnosis and treatment are changing the lives of people diagnosed with lung cancer.
Funded more grants for lung cancer research
In 2020, in partnership with the International Association for the Study of Lung Cancer and Bristol-Myers Squibb, LCFA funded $800,000 in lung cancer research grants. Meet the Young Investigators of 2020:
Dr. Triparna Sen, Assistant Attending
Dr. Jon Zugazagoitia, Attending Physician-Scientist
Dr. Vincent Lam, Assistant Professor of Oncology
Dr. Adrian Sacher, Assistant Professor in the Division of Medical Oncology & Hematology
In our decade-plus history, LCFA has been able to award 6-figure lung cancer research grants, annually.
Launched a complementary podcast to the video series.
In 2020, LCFA expanded Hope With Answers℠, an on-demand video series by delivering message points via podcasts.
The Hope With Answers: Living With Lung Cancer℠ podcasts launched in January 2020. With the COVID Lockdown in March 2020, topics of the podcasts quickly pivoted to COVID topics designed to help lung cancer patients and caregivers navigate the uncharted waters of a global pandemic.
In 2020, the Hope With Answers: Living With Lung Cancer podcasts gained 13K users adding to the already strong viewer numbers from the Hope With Answers videos.
Amplified our awareness messaging
lung cancer awareness
As a result, LCFA is staying on course for funding impactful lung cancer research by:
- The innovative partnership with IASLC to fund young investigators in lung cancer research since 2012.
- Building a network of leading lung cancer doctors to help educate and explain the latest research and clinical trials.